Annual FCF
-$6.63 M
+$2.23 M+25.20%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual free cash flow is -$6.63 million, with the most recent change of +$2.23 million (+25.20%) on December 1, 2023.
- During the last 3 years, XRTX annual FCF has fallen by -$6.05 million (-1038.11%).
- XRTX annual FCF is now -10690.26% below its all-time high of $62.60 thousand, reached on December 1, 2017.
Performance
XRTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$775.00 K
-$29.40 K-3.94%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly free cash flow is -$775.00 thousand, with the most recent change of -$29.40 thousand (-3.94%) on September 1, 2024.
- Over the past year, XRTX quarterly FCF has increased by +$532.90 thousand (+40.74%).
- XRTX quarterly FCF is now -167.73% below its all-time high of $1.14 million, reached on December 1, 2020.
Performance
XRTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$4.13 M
+$303.00 K+6.83%
September 1, 2024
Summary
- As of February 7, 2025, XRTX TTM free cash flow is -$4.13 million, with the most recent change of +$303.00 thousand (+6.83%) on September 1, 2024.
- Over the past year, XRTX TTM FCF has increased by +$2.49 million (+37.63%).
- XRTX TTM FCF is now -18526.13% below its all-time high of -$22.20 thousand, reached on November 1, 2014.
Performance
XRTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
XRTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.2% | +40.7% | +37.6% |
| 3 y3 years | -1038.1% | +69.1% | +54.1% |
| 5 y5 years | -465.6% | +69.1% | +54.1% |
XRTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.5% | +25.2% | -3.9% | +78.7% | at high | +54.1% |
| 5 y | 5-year | -3273.8% | +25.2% | -167.7% | +78.7% | -3782.6% | +54.1% |
| alltime | all time | <-9999.0% | +25.2% | -167.7% | +78.7% | <-9999.0% | +54.1% |
XORTX Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$775.00 K(+3.9%) | -$4.13 M(-6.8%) |
| Jun 2024 | - | -$745.60 K(-42.9%) | -$4.44 M(-18.3%) |
| Mar 2024 | - | -$1.31 M(-0.1%) | -$5.43 M(-18.1%) |
| Dec 2023 | -$6.63 M(-25.2%) | -$1.31 M(+21.3%) | -$6.63 M(-25.9%) |
| Sep 2023 | - | -$1.08 M(-38.0%) | -$8.95 M(+1.2%) |
| Jun 2023 | - | -$1.74 M(-30.6%) | -$8.85 M(-1.8%) |
| Mar 2023 | - | -$2.50 M(-31.0%) | -$9.01 M(-0.0%) |
| Dec 2022 | -$8.86 M(+85.2%) | -$3.63 M(+273.4%) | -$9.01 M(+5.5%) |
| Sep 2022 | - | -$972.20 K(-48.8%) | -$8.54 M(+12.5%) |
| Jun 2022 | - | -$1.90 M(-24.2%) | -$7.59 M(+18.4%) |
| Mar 2022 | - | -$2.51 M(-20.7%) | -$6.41 M(+32.7%) |
| Dec 2021 | -$4.79 M(+721.6%) | - | - |
| Dec 2021 | - | -$3.16 M(>+9900.0%) | -$4.83 M(+816.9%) |
| Sep 2021 | - | -$24.30 K(-96.6%) | -$527.10 K(-16.1%) |
| Jun 2021 | - | -$720.20 K(-22.3%) | -$628.20 K(+489.9%) |
| Mar 2021 | - | -$926.80 K(-181.0%) | -$106.50 K(-81.7%) |
| Dec 2020 | -$582.50 K(+196.4%) | $1.14 M(-1012.4%) | -$582.50 K(-67.8%) |
| Sep 2020 | - | -$125.40 K(-36.8%) | -$1.81 M(+8.0%) |
| Jun 2020 | - | -$198.50 K(-85.8%) | -$1.68 M(+10.9%) |
| Mar 2020 | - | -$1.40 M(+1610.7%) | -$1.51 M(+669.6%) |
| Dec 2019 | -$196.50 K | -$82.00 K(-1138.0%) | -$196.40 K(+30.8%) |
| Sep 2019 | - | $7900.00(-122.9%) | -$150.20 K(-55.3%) |
| Jun 2019 | - | -$34.50 K(-60.7%) | -$336.30 K(-32.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$87.80 K(+145.3%) | -$497.30 K(-57.6%) |
| Dec 2018 | -$1.17 M(-1972.4%) | -$35.80 K(-79.9%) | -$1.17 M(+0.7%) |
| Sep 2018 | - | -$178.20 K(-8.8%) | -$1.16 M(+11.3%) |
| Jun 2018 | - | -$195.50 K(-74.4%) | -$1.05 M(+17.7%) |
| Mar 2018 | - | -$762.60 K(+2663.0%) | -$888.40 K(+461.2%) |
| Dec 2017 | $62.60 K(-143.1%) | - | - |
| Nov 2017 | - | -$27.60 K(-53.7%) | -$158.30 K(-27.3%) |
| Aug 2017 | - | -$59.60 K(+54.4%) | -$217.70 K(+33.7%) |
| May 2017 | - | -$38.60 K(+601.8%) | -$162.80 K(+10.9%) |
| Mar 2017 | - | -$5500.00(-79.6%) | -$146.80 K(+3.9%) |
| Feb 2017 | -$145.10 K(+47.3%) | -$27.00 K(-69.0%) | -$141.30 K(+11.4%) |
| Dec 2016 | -$98.50 K(-41.3%) | - | - |
| Nov 2016 | - | -$87.00 K(+1751.1%) | -$126.80 K(-31.2%) |
| Aug 2016 | - | -$4700.00(-79.2%) | -$184.20 K(-2.4%) |
| May 2016 | - | -$22.60 K(+80.8%) | -$188.80 K(+12.6%) |
| Feb 2016 | -$167.70 K(+53.2%) | -$12.50 K(-91.3%) | -$167.70 K(-30.8%) |
| Nov 2015 | - | -$144.40 K(+1452.7%) | -$242.50 K(+150.3%) |
| Aug 2015 | - | -$9300.00(+520.0%) | -$96.90 K(+10.9%) |
| May 2015 | - | -$1500.00(-98.3%) | -$87.40 K(-20.2%) |
| Feb 2015 | -$109.50 K | -$87.30 K(-7375.0%) | -$109.50 K(+393.2%) |
| Nov 2014 | - | $1200.00(+500.0%) | -$22.20 K(-5.1%) |
| Aug 2014 | - | $200.00(-100.8%) | -$23.40 K(-0.8%) |
| May 2014 | - | -$23.60 K | -$23.60 K |
FAQ
- What is XORTX Therapeutics annual free cash flow?
- What is the all time high annual FCF for XORTX Therapeutics?
- What is XORTX Therapeutics annual FCF year-on-year change?
- What is XORTX Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly FCF year-on-year change?
- What is XORTX Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for XORTX Therapeutics?
- What is XORTX Therapeutics TTM FCF year-on-year change?
What is XORTX Therapeutics annual free cash flow?
The current annual FCF of XRTX is -$6.63 M
What is the all time high annual FCF for XORTX Therapeutics?
XORTX Therapeutics all-time high annual free cash flow is $62.60 K
What is XORTX Therapeutics annual FCF year-on-year change?
Over the past year, XRTX annual free cash flow has changed by +$2.23 M (+25.20%)
What is XORTX Therapeutics quarterly free cash flow?
The current quarterly FCF of XRTX is -$775.00 K
What is the all time high quarterly FCF for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly free cash flow is $1.14 M
What is XORTX Therapeutics quarterly FCF year-on-year change?
Over the past year, XRTX quarterly free cash flow has changed by +$532.90 K (+40.74%)
What is XORTX Therapeutics TTM free cash flow?
The current TTM FCF of XRTX is -$4.13 M
What is the all time high TTM FCF for XORTX Therapeutics?
XORTX Therapeutics all-time high TTM free cash flow is -$22.20 K
What is XORTX Therapeutics TTM FCF year-on-year change?
Over the past year, XRTX TTM free cash flow has changed by +$2.49 M (+37.63%)